<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content

About Us

Founded with the goal of developing first-in-class medicines for patients with the most unmet needs,
at a pace and efficiency never achieved before.
DeepEngage_icon_white-1

Our Story

Armed with an ever-growing understanding of cancer biology, Corellia AI was launched out of Champions Oncology, Inc. in 2023, leveraging Champions’ deep cancer dataset, rich suite of research platforms, and state-of-the-art experimental capabilities established over the past 15 years. 

Corellia AI has built a unique research ecosystem and partnered with world-leading biopharma and technology companies to execute our vision of building transformative first-in-class therapeutics. 

History of Corellia AI

Corellia Timeline_Mike_2
Corellia AI launched out of Champions Oncology, a technology-driven research organization formed in 2008, leveraging the unique platform consisting of a world-leading bank of PDX models, a multi-omic dataset, and extensive experimental capabilities.

Meet The Team

Corellia AI empowers a global team of passionate scientists, drug developers, and innovators. We combine our collective human intelligence with powerful artificial intelligence to revolutionize the discovery of novel oncology therapeutics

Ronnie2024Ronnie Morris, MD
Executive Chairman

Chief Executive Officer of Champions Oncology. One of the founders of MDVIP, the national leader in personalized healthcare. 
Mike2024

Michael Ritchie, PhD, MBA
Chief Executive Officer

Chief Commercial Officer of Champions Oncology and founder of the Lumin Bioinformatics Platform and Corellia AI. Former research scientist at Pfizer GBT/Oncology.  PhD in Biochemistry from Temple University, MBA (finance focus) NYU Stern.
Kakajan2024

Kakajan Komurov, PhD
Chief Scientific/Technology Officer

 

Led target and drug discovery at Champions Oncology, co-founding Corellia AI.  Senior Director in Molecular Discovery at Pfizer Oncology leading a group of 20 scientists.  
Josh2024

Josh Levine, JD
Chief Business Officer

Previously Chief Executive Officer and Chairman of Proteologics.  Has 20+ years of biopharma business development and executive leadership.